Form 4 holding
President, Director
GYRE THERAPEUTICS, INC.
- Security class
- Common Stock
- Shares / value
- 2,806,084
- Estimated value
- $28,257,265
- Report date
- 28 May 2025
- Price
- $10.07
- Ownership
- By Spouse
Songjiang Ma - President, Director at GYRE THERAPEUTICS, INC.
Issuer-level insider activity
- Role
- President, Director
- Issuer ticker
- GYRE on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Songjiang Ma since 11 Sep 2025
Reported holdings for Songjiang Ma in GYRE THERAPEUTICS, INC.
Form 4 holding
President, Director
GYRE THERAPEUTICS, INC.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 26,000
- Estimated value
- Report date
- 14 Aug 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Songjiang Ma in GYRE THERAPEUTICS, INC.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.